Tag:
Beckman Coulter
Latest Headlines
Latest Headlines
Danaher to buy Beckman Coulter for $83.50 per share
Danaher Corporation has entered a definitive merger agreement through which it will buy Beckman Coulter ( $BEC ) for $83.50 per share in cash. The transaction is valued at approximately $6.8 billion,
Beckman Coulter ($BEC) researching public vs. private future
After some recent troubles and a few buyout offers, Beckman Coulter ( $BEC ) has turned to analysts as it determines its future in either the public or private sector. According to Bloomberg, General
Garrett resigns as Beckman Coulter CEO
J. Robert Hurley has been named the interim president and CEO of Beckman Coulter following Scott Garrett's announcement that he is resigning as chairman, president and CEO of the company. Garrett
Clinical Data sells genomics services unit for $17M
Clinical Data is moving forward with its initiative to sell off some of its assets in order to advance its late stage drug development programs. The company announced today that it has completed an
Beckman Coulter buys diagnostic biz for $800M
Beckman Coulter is expanding its clinical chemistry business with the purchase of Tokyo-based Olympus' Life Sciences diagnostic systems. The deal is worth ¥77.45 billion--about $800 million.
